Sotera Health Company (SHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 44,398 | 51,376 | -233,570 | 117,121 | -37,491 |
| Depreciation Amortization | 170,875 | 166,976 | 160,848 | 157,063 | 155,187 |
| Income taxes - deferred | 9,433 | 3,449 | -73,960 | -3,716 | -23,360 |
| Accounts receivable | 2,216 | -21,724 | -12,555 | -15,509 | 1,942 |
| Accounts payable and accrued liabilities | -6,644 | -5,333 | 1,107 | 19,761 | -6,022 |
| Other Working Capital | -42,634 | -403,285 | 409,234 | -12,591 | -11,793 |
| Other Operating Activity | 46,520 | 60,809 | 26,857 | 19,416 | 42,122 |
| Operating Cash Flow | $224,164 | $-147,732 | $277,961 | $281,545 | $120,585 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -179,070 | -214,975 | -182,378 | -102,162 | -53,507 |
| Other Investing Activity | 74 | 69 | 482 | -57,671 | -105,187 |
| Investing Cash Flow | $-178,996 | $-214,906 | $-181,896 | $-159,833 | $-158,694 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,259,350 | 500,000 | 200,000 | N/A | 150,000 |
| Debt Repayment | -2,264,373 | -202,500 | N/A | -100,000 | -1,177,325 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 1,155,961 |
| Common Stock Repurchased | N/A | N/A | N/A | -8,418 | -34,000 |
| Other Financing Activity | -45,541 | -31,541 | -2,239 | -8,868 | -21,204 |
| Financing Cash Flow | $-50,564 | $265,959 | $197,761 | $-117,286 | $73,432 |
| Exchange Rate Effect | -17,393 | 2,039 | -4,456 | 44 | 4,106 |
| Beginning Cash Position | 301,654 | 396,294 | 106,924 | 102,454 | 63,025 |
| End Cash Position | 278,865 | 301,654 | 396,294 | 106,924 | 102,454 |
| Net Cash Flow | $-22,789 | $-94,640 | $289,370 | $4,470 | $39,429 |
| Free Cash Flow | |||||
| Operating Cash Flow | 224,164 | -147,732 | 277,961 | 281,545 | 120,585 |
| Capital Expenditure | -179,070 | -214,975 | -182,378 | -102,162 | -53,507 |
| Free Cash Flow | 45,094 | -362,707 | 95,583 | 179,383 | 67,078 |